| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* | 
|---|---|---|---|---|---|---|---|---|---|---|
| Europe (Primary) | PRIMARYEUR | Univ | 6,317 | 20,295,712 | -0.43% | -0.52% | 0.98% | 5.49% | 8.71% | 17.65% | 
| Healthcare | HEALTHCARE | Sector | 582 | 2,155,709 | -0.34% | -1.75% | -1.10% | 9.91% | 6.33% | -2.61% | 
| Biopharmaceuticals | BIOPHARMA | SubSec | 182 | 1,648,885 | -0.51% | -1.72% | -2.22% | 12.52% | 8.07% | -3.58% | 
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 53 | 39,155 | -0.19% | -1.95% | -4.43% | 19.44% | 29.09% | 15.65% | 
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,807 | 0.13% | -1.34% | -2.17% | 0.59% | 35.49% | 20.54% | 
 
			| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* | 
|---|---|---|---|---|---|---|---|---|---|---|
| Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,872 | -0.29% | -1.08% | 4.32% | 1.27% | 50.84% | 9.48% | 
| Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,317 | 20,295,712 | -0.52% | -0.56% | 0.76% | 6.47% | 7.53% | 16.04% | 
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,807 | 0.13% | -1.34% | -2.17% | 0.59% | 35.49% | 20.54% | 
| Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 710 | 0.54% | -3.02% | -3.53% | -13.25% | 5.92% | 6.53% | 
| Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 757 | 1.25% | -0.54% | -19.10% | 16.48% | 42.83% | 56.42% | 
* Colors indicate performance relative to the benchmark.